[Skip to the reading](#reading)

Care decisions begin with clear questions

[Irvine Peptide Clinic](/)

An Irvine starting path, one stage after another. Nobody prescribes from this site.

[Back to the starting path](/)

# Make the first care decision

Put your health question ahead of a treatment name. Then work through the product details, the license record, and the route for further questions.

A search result is a place to gather questions. It is not a decision about what fits your health.

On this page

[Name the problem in your own words](#note-1)

[Identify the kind of medicine](#note-2)

[Check who would assess you](#note-3)

[Choose how to have the conversation](#note-4)

[Keep the next step small](#note-5)

## Name the problem in your own words

Maybe an ad caught your eye. Maybe someone mentioned a treatment, and now you are trying to work out what it means. Begin with what brought you here. Write down the change you hope for, what troubles you most, and any steps you have already taken. A useful opening for a visit is a description of your concern. It does not have to be a request for a particular product.

A peptide is a brief chain of amino acids, the units that form proteins; the word describes its makeup, rather than a kind of care.

[Source: FDA on medicine preparation](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers)

That leaves a practical question: what exact substance is being discussed? Ask for the full name, not just a category such as wellness or recovery. Keep that name with your questions.

## Identify the kind of medicine

The federal agency named Food and Drug Administration uses FDA for short. In compounding, a doctor or pharmacist makes the drug; the person does not receive a manufacturer’s finished product.

[Source: FDA on medicine preparation](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers)

As of September 26, 2026, peptide care could involve an FDA-approved drug, a compounded preparation, or an unapproved product; those positions are different.

[Source: FDA on medicine preparation](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers)

For a compounded drug, the September 2026 position is that FDA has not reviewed its quality, safety, or effectiveness before sale.

[Source: FDA on medicine preparation](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers)

Ask which category the proposed product belongs to. A polished website is no answer to that question. Keep the answer in plain words, alongside the exact name.

## Check who would assess you

For a person in Irvine, the California Medical Board says a doctor providing telehealth needs a current California license, even if the doctor lives elsewhere; this rule was checked September 28, 2026.

[Source: State remote-care rules](https://www.mbc.ca.gov/Resources/Medical-Resources/telehealth.aspx)

Telehealth means care by a remote connection, such as video or an online exchange. Before arranging it, ask who will conduct the assessment and what professional license that person holds. A business name alone does not give you a person to check. The license notes show where to take the name and which state board to choose.

## Choose how to have the conversation

Consider what you want from the visit. Is it easier to describe the concern face to face, or would a remote conversation fit your day? Ask how the service handles questions that need more discussion. Ask what happens if the person assessing you needs information that cannot be gathered through that visit.

California can allow an assessment before prescribing through telehealth, including a questionnaire. The law checked September 26, 2026 still requires the care standard to be met: the reviewer must gather enough information about your health concern to make the care decision properly. A form alone does not show that this condition has been met. Ask what information the reviewer needs and where you would go for any examination or test needed for the decision.

[Source: State prior-exam law](https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=BPC&sectionNum=2242)

## Keep the next step small

Leave your search with something concrete: a concern to discuss, a full product name if one has been proposed, and a person whose license you can look up. There is no need to collect every unfamiliar term before speaking with someone. If the product or process is still unclear, make that the next question. The point of preparation is a clearer conversation, with room to hear an answer you did not expect.

## Continue with a practical check

[Choose a setting for care](/care-options-notes)

Irvine Peptide Clinic

Irvine Peptide Clinic is a guide for the choices before care, not a clinic and never a medicine shop.

## Get oriented

[First care decisions](/field-guide)

[The exact medicine](/medicine-field-notes)

[Compounding](/compounding-field-notes)

## Check the basics

[California checks](/california-field-notes)

[Professional licenses](/license-field-notes)

[Pharmacy checks](/pharmacy-field-notes)

[When to pause](/risk-notes)

## Compare the plan

[Care settings](/care-options-notes)

[Remote visits](/telehealth-field-notes)

[Full costs](/cost-notes)

[Insurance questions](/insurance-notes)

## Prepare to talk

[Visit preparation](/visit-field-notes)

[Common questions](/field-questions)

[Claims and sources](/notes-and-sources)

© Irvine Peptide Clinic

[Read this page as text](/field-guide.md)

[Return to the starting path](/)
